2016-03-03T00:00:00.000-05:00
business’s revenue,-0.45679
Piper Jaffray,0.228986
Creative Planning,0.361037
earnings results,-0.269972
quarter worth,0.449443
strong buy rating,0.308402
Russell Frank,0.584977
price target,0.27242
business’s stock,-0.230173
chief executive officer,0.232294
stock,0.0345592
Ionis Pharmaceuticals,0.00588477
institutional investors,-0.208218
InvestorPlace Broker Center,0.555736
British Columbia Investment,0.374427
antisense drugs,-0.430576
1-year high,-0.612069
hedge funds,-0.208218
personal trading style,0.598412
Pharmaceuticals Inc Daily,0.397938
recent reporting period,-0.312648
research note,0.27242
Stanley T. Crooke,-0.230173
senior vice president,0.213586
equities research analysts,0.234126
Mackay Shields,0.388924
BLB&B Advisors,0.383968
average price,-0.246197
shares,0.106546
consensus estimate,0.21105
concise daily summary,0.505807
average target price,-0.330429
stock broker,0.245696
company,0.310765
consensus rating,0.323461
development company,0.239897
rating,0.303172
Scout Investments Inc.,-0.312648
Management Corp,0.374427
new position,0.449443
